Received prior radiotherapy to any portion of the abdominal cavity or pelvis
Patients with extra-abdominal metastatic disease
Radiation to the abdominal area within 28 days of first dose of therapy
Patients who have had prior abdominal radiotherapy
Subjects who have received prior radiotherapy to any portion of the abdominal cavity or pelvis are excluded
Prior radiation to the liver or other upper abdominal regions
Known or suspected extensive abdominal adhesions
Prior radiotherapy to any portion of the abdominal cavity or pelvis
Patients must be reasonable candidates for laparoscopy and IP platinum regimen with no prior evidence of clinically significant intra-abdominal adhesions, persistent abdominal wall infections, renal toxicity, or bowel obstruction
Prior abdominal radiotherapy
Prior history of abdominal radiation therapy
Patients with prior radiation to the abdominal cavity or pelvis are excluded
Subjects received previous abdominal radiation
Intra-abdominal disease > 8 cm in diameter at the time of registration, intrahepatic disease, or disease beyond the abdominal cavity; patients with intra-abdominal lymph node involvement are eligible based on biodistribution data indicating viral dissemination to lymph nodes following intraperitoneal administration
Prior history of abdominal radiation therapy
No prior abdominal radiation
Radiologic workup must demonstrate that the disease is confined to the abdominal cavity and/or is not metabolically active on PET (positron emission tomography scan), outside of the abdominal cavity
Patients will be ineligible if they have disease outside of the abdominal cavity which is uncontrolled or PET avid
Received prior radiotherapy to any portion of the abdominal cavity or pelvis.
Patients who have received prior radiotherapy to any portion of the abdominal cavity or pelvis are excluded
Patient must be eligible for abdominal surgery
Subjects who have received prior radiation therapy to any portion of the abdominal cavity or pelvis are excluded; prior intravaginal brachytherapy is permitted; prior radiation therapy for breast cancer is permitted
Radiologic workup must demonstrate that the disease is confined to the abdominal cavity and/or is controlled outside of the abdominal cavity
Patients will be ineligible if they have disease outside of the abdominal cavity which is uncontrolled
Patients who have had prior abdominal radiotherapy
Patients with liver metastases cannot have received prior upper abdominal radiation
Patients who have received previous abdominal radiation
Patients who have had prior abdominal radiotherapy
Prior abdominal radiotherapy
Patients with evidence of abdominal free air not explained by paracentesis
Pfannenstiel or transverse abdominal incision
